T cell receptor alpha-beta (αβ) (TCRαβ)

The T cell receptor alpha-beta (TCRαβ) is a heterodimeric cell surface protein expressed predominantly on most mature T lymphocytes, comprising an alpha chain and a beta chain, each featuring variable and constant regions[5][8][3]. The variable regions of both chains form the antigen-binding site, which recognizes processed antigenic peptides presented by major histocompatibility complex (MHC) molecules[5][8]. TCR diversity arises from V(D)J recombination, allowing each T cell to express a unique receptor specificity, essential for recognizing diverse pathogens and antigens[7][3][6]. The TCRαβ heterodimer signals via association with CD3 proteins (γ, δ, ε, ζ), and this signaling drives central immunological processes such as T cell activation, proliferation, differentiation, and effector functions in immune response[9][3]. Structural and biophysical analyses have shown that TCRs also recognize non-peptide antigens presented by CD1 (lipids) and MR1 (small metabolites), further underscoring their role in immunity[8]. Dysfunction or aberrant signaling via TCRαβ is implicated in a range of diseases including cancers, autoimmune conditions, infections, and transplant-related complications[8][9]. Note: The alpha and beta chains are not used as clinical drug targets individually; therapeutic modulation targets the intact receptor complex or associated signal transduction elements. Your target should be structured as "T cell receptor alpha-beta" for standardized data mapping.

Other names

TCR alpha-betaTCRαβT cell antigen receptorTCRαβ T cell receptor

Binding/blocking antigen recognition Modulating T cell activation Immune cell depletion or suppression (via CD3, not the αβ chains directly)